What Factors Determine the Quality of an Active Pharmaceutical Ingredient?

A quality auditor for a generic drug manufacturer visits two suppliers of the same Active Pharmaceutical Ingredients. Both suppliers provide a certificate of analysis showing a purity of 99.5 percent. Both suppliers are ISO 9001 certified. Both suppliers offer a competitive price. The auditor approves both suppliers. Six months later, one supplier's material is causing batch failures due to an unknown impurity peak at 0.15 percent. The other supplier's material has been problem-free. The difference is not the purity number on the certificate. It is the impurity profile, the analytical method used to generate the certificate, and the change control system that governs the process. This guide explains what quality auditors should look for beyond the certificate.

1. Why Is the Impurity Profile More Important Than the Purity Number?

The purity number on a certificate of analysis is the area percentage of the main peak in an HPLC chromatogram. It tells you how much of the material is the desired molecule. It does not tell you what the remaining 0.5 percent is. The remaining 0.5 percent could be residual solvents, inorganic impurities, or organic impurities that are structurally related to the Active Pharmaceutical Ingredients. Some of these impurities are toxicologically significant even at low levels. The table below shows the categories of impurities and their typical limits.

The auditor should request the full impurity profile, not just the summary purity. The profile should list each impurity with its retention time, its relative retention time, and its limit. The method should be validated for specificity, linearity, accuracy, and precision. In our factory, we provide a complete impurity profile with every batch of Active Pharmaceutical Ingredients. Henan Purui Pharmaceutical Co., Ltd. has been manufacturing APIs for over 15 years and has a dedicated analytical team that develops and validates the methods for each product.

2. How Does the Manufacturing Process Affect Impurity Formation?

The impurity profile is determined by the manufacturing process. The route of synthesis, the solvents, the catalysts, and the purification steps all affect which impurities are formed and at what levels. A supplier that uses a well-designed process with robust purification will produce a cleaner material. A supplier that uses a short-cut process may have higher levels of process-related impurities. The table below shows the effect of process design on impurity levels.

In our factory, we use a convergent synthesis route that minimizes the number of late-stage impurities. We also use a final crystallization step that removes the majority of process-related impurities. The impurity profile of our Active Pharmaceutical Ingredients is consistently below 0.10 percent for each individual impurity. Purui provides a process description in the drug master file (DMF) that supports our customers' regulatory filings.

3. What Stability Data Is Required to Support Quality Claims?

The quality of an Active Pharmaceutical Ingredients is not just a snapshot at the time of manufacture. It is the ability to maintain that quality over the shelf life. The supplier must provide stability data that supports the retest period or the expiry date. The stability data should include accelerated conditions (40°C / 75% RH for 6 months) and long-term conditions (25°C / 60% RH or 30°C / 65% RH for 12 to 36 months). The table below shows the stability data requirements for different climatic zones.

4. How Does Change Control Affect Long-Term Quality?

Change control is the system that governs changes to the manufacturing process, the analytical methods, and the raw material suppliers. A robust change control system ensures that any change is evaluated for its impact on quality and that the customer is notified before the change is implemented. A weak change control system allows changes to be made without notification, which can cause batch failures at the customer's site. The table below shows the elements of a robust change control system.

In our factory, we have a formal change control procedure that requires customer approval before any change that affects the impurity profile, the physical properties, or the regulatory filing. We also maintain a change history log that is available to our customers during audits. Purui has never had a customer batch failure caused by an unannounced change. We believe that transparency in change control is the foundation of a long-term supply relationship.

Summary for Quality Auditors and Procurement Managers

The quality of an Active Pharmaceutical Ingredients is determined by the impurity profile, the manufacturing process, the stability data, and the change control system. The purity number on the certificate of analysis is only the starting point. Auditors should request the full impurity profile, verify that the analytical methods are validated, review the stability data for the relevant climatic zone, and evaluate the robustness of the change control system. By looking beyond the certificate, auditors can identify suppliers that provide consistent, high-quality APIs and avoid the hidden risks that cause batch failures. Henan Purui Pharmaceutical Co., Ltd. has been manufacturing Active Pharmaceutical Ingredients for over 15 years and provides full documentation and audit support for our customers.

Henan Purui Pharmaceutical Co., Ltd. manufactures Active Pharmaceutical Ingredients with complete impurity profiles, validated analytical methods, and stability data for all climatic zones. We maintain active drug master files and provide letters of authorization for our customers' regulatory filings.